Dominique Dive
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dominique Dive has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Alexander De Cock
Nationaal Multiple Sclerose Centrum Melsbroek Belgium
2 shared publications - Guy Nagels
Vrije Universiteit Brussel
2 shared publications - Hélène Zéphir
University of Lille, Neurology, Inserm U 1172, CHU of Lille, France
2 shared publications - Jeroen Van Schependom
Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel, Brussels, Belgium
2 shared publications - Johan Baijot
AIMS lab, Center for Neurosciences, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium
2 shared publications - Johan De Mey
Department of Radiology, Universitair Ziekenhuis Brussel, Brussels, Belgium
2 shared publications
Latest Publications
- Open Access
- 11 July 2022
- Published by Wiley in European Journal of Neurology
- Vol. 29 (10) , 3039-3049
Brain age as a surrogate marker for cognitive performance in multiple sclerosis
Background and purpose: Data from neuro‐imaging techniques allow us to estimate a brain's age. Brain age is easily interpretable as ‘how old the brain looks’ and could therefore be an attractive communication tool for brain health in clinical practice. This study aimed to investigate its clinical utility by investigating the relationship between brain age and cognitive performance in multiple sclerosis (MS).Methods: A linear regression model was trained to predict age from brain magnetic resonance imaging volumetric features and sex in a healthy control dataset (HC_train, n = 1673). This model was used to predict brain age in two test sets: HC_test (n = 50) and MS_test (n = 201). Brain‐predicted age difference (BPAD) was calculated as BPAD = brain age minus chronological age. Cognitive performance was assessed by the Symbol Digit Modalities Test (SDMT).Results: Brain age was significantly related to SDMT scores in the MS_test dataset (r = −0.46, p < 0.001) and contributed uniquely to variance in SDMT beyond chronological age, reflected by a significant correlation between BPAD and SDMT (r = −0.24, p < 0.001) and a significant weight (−0.25, p = 0.002) in a multivariate regression equation with age.Conclusions: Brain age is a candidate biomarker for cognitive dysfunction in MS and an easy to grasp metric for brain health.
- 11 July 2022
- Published by Wiley in European Journal of Neurology
- Vol. 29 (10) , 3039-3049
Open AccessBrain age as a surrogate marker for cognitive performance in multiple sclerosis
Background and purpose: Data from neuro‐imaging techniques allow us to estimate a brain's age. Brain age is easily interpretable as ‘how old the brain looks’ and could therefore be an attractive communication tool for brain health in clinical practice. This study aimed to investigate its clinical utility by investigating the relationship between brain age and cognitive performance in multiple sclerosis (MS).Methods: A linear regression model was trained to predict age from brain magnetic resonance imaging volumetric features and sex in a healthy control dataset (HC_train, n = 1673). This model was used to predict brain age in two test sets: HC_test (n = 50) and MS_test (n = 201). Brain‐predicted age difference (BPAD) was calculated as BPAD = brain age minus chronological age. Cognitive performance was assessed by the Symbol Digit Modalities Test (SDMT).Results: Brain age was significantly related to SDMT scores in the MS_test dataset (r = −0.46, p < 0.001) and contributed uniquely to variance in SDMT beyond chronological age, reflected by a significant correlation between BPAD and SDMT (r = −0.24, p < 0.001) and a significant weight (−0.25, p = 0.002) in a multivariate regression equation with age.Conclusions: Brain age is a candidate biomarker for cognitive dysfunction in MS and an easy to grasp metric for brain health.
- Open Access
Brain age as a surrogate marker for information processing speed in multiple sclerosis
Background Data from neuro-imaging techniques allow us to estimate a brain’s age. Brain age is easily interpretable as “how old the brain looks”, and could therefore be an attractive communication tool for brain health in clinical practice. This study aimed to investigate its clinical utility. Objectives To investigate the relationship between brain age and information processing speed in MS. Methods A ridge-regression model was trained to predict age from brain MRI volumetric features and sex in a healthy control dataset (HC_train, n=1690). This model was used to predict brain age in two test sets: HC_test (n=50) and MS_test (n=201). Brain-Predicted Age Difference (BPAD) was calculated as BPAD=brain age minus chronological age. Information processing speed was assessed with the Symbol Digit Modalities Test (SDMT). Results Brain age was significantly related to SDMT scores in the MS_test dataset (r=-0.44, p<.001), and contributed uniquely to variance in SDMT beyond chronological age, reflected by a significant correlation between BPAD and SDMT (r=-0.21, p=0.003) and a significant weight (−0.21, p=0.011) in a multivariate regression equation with age. Conclusions Brain age is a candidate biomarker for information processing speed in MS and an easy to grasp metric for brain health.
Open AccessBrain age as a surrogate marker for information processing speed in multiple sclerosis
Background Data from neuro-imaging techniques allow us to estimate a brain’s age. Brain age is easily interpretable as “how old the brain looks”, and could therefore be an attractive communication tool for brain health in clinical practice. This study aimed to investigate its clinical utility. Objectives To investigate the relationship between brain age and information processing speed in MS. Methods A ridge-regression model was trained to predict age from brain MRI volumetric features and sex in a healthy control dataset (HC_train, n=1690). This model was used to predict brain age in two test sets: HC_test (n=50) and MS_test (n=201). Brain-Predicted Age Difference (BPAD) was calculated as BPAD=brain age minus chronological age. Information processing speed was assessed with the Symbol Digit Modalities Test (SDMT). Results Brain age was significantly related to SDMT scores in the MS_test dataset (r=-0.44, p<.001), and contributed uniquely to variance in SDMT beyond chronological age, reflected by a significant correlation between BPAD and SDMT (r=-0.21, p=0.003) and a significant weight (−0.21, p=0.011) in a multivariate regression equation with age. Conclusions Brain age is a candidate biomarker for information processing speed in MS and an easy to grasp metric for brain health.
- 12 February 2013
- Published by Wolters Kluwer Health in Neurology
- Vol. 80 (7_suppleme)
ENIGM: A French Observational Study about Switching from Natalizumab to Fingolimod in Multiple Sclerosis (S41.002)
- 12 February 2013
- Published by Wolters Kluwer Health in Neurology
- Vol. 80 (7_suppleme)
ENIGM: A French Observational Study about Switching from Natalizumab to Fingolimod in Multiple Sclerosis (S41.002)